Business Context and Reporting Period
Company: ALPHA PRO TECH LTD
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2000
Business Overview: The Company manufactures and distributes disposable masks, shields, shoe covers, apparel, food service, and woundcare products. Primary markets include medical, dental, industrial, clean room, and pet supply sectors, predominantly in the United States.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2000 |
Nine Months Ended Sep 30, 2000 |
Nine Months Ended Sep 30, 1999 |
|---|---|---|---|
| Sales (Revenue) | $5,444,000 | $15,515,000 | $14,888,000 |
| Gross Profit | $2,340,000 | $6,463,000 | $5,882,000 |
| Gross Margin | 43.0% | 41.7% | 39.5% |
| Net Income | $419,000 | $1,173,000 | $792,000 |
| EPS (Diluted) | $0.02 | $0.05 | $0.03 |
| Operating Cash Flow | N/A | $792,000 | $840,000 |
| Cash & Equivalents | $1,043,000 | $1,043,000 | $613,000 |
| Working Capital | $5,438,000 | $5,438,000 | N/A |
| Total Debt (Current + Long Term) | $1,139,000 | $1,139,000 | $957,000 |
Note: Total Debt includes Notes Payable and Capital Leases. Current portion of Notes Payable is $942,000; Long-term is $118,000. Current Capital Leases are $79,000; Long-term is $1,000.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 5.2% for the quarter and 4.2% year-to-date compared to 1999. The Apparel segment drove growth with a 7.4% quarterly increase, attributed to the Company's largest distributor.
- Profitability: Net income surged 73.9% for the quarter and 48.1% year-to-date. This was driven by a significant improvement in gross margins (up to 43.0% from 37.3% in the prior quarter) and a 92.7% reduction in net interest expense.
- Expense Management: Selling, General, and Administrative (SG&A) expenses increased 18.1% for the quarter and 7.1% year-to-date, primarily due to higher payroll, marketing, and public company compliance costs.
- Segment Performance:
- Mask & Shield: Sales up 1.1% quarterly and 10.5% year-to-date, led by a 29.6% increase in medical mask sales.
- Fleece/Pet: Pet bed sales increased 29.0% year-to-date, offsetting a decline in medical fleece products.
- Food Service: New revenue stream generated $45,000 in the third quarter (nil in prior year) following a new vendor agreement.
Guidance, Outlook, and Risks
- Outlook: Management expects record sales and net income for fiscal year 2000. Gross margins are projected to remain strong due to manufacturing efficiency improvements.
- Capital Expenditures: The Company plans to invest approximately $800,000 over the next 12 months to upgrade mask manufacturing capabilities ($300,000) and acquire automated shoecover equipment ($200,000), in addition to recent spending on an extrusion coating machine.
- Liquidity: The Company maintains a $3,500,000 line of credit with $1,513,000 currently unused. Management believes current cash and credit facilities are sufficient for operations and planned capital expenditures for at least 12 months.
- Risks & Contingencies:
- Concentration Risk: A significant portion of revenue is derived from a single largest distributor in the industrial cleanroom market.
- Market Volatility: The medical market (specifically fleece bed pads) is down year-to-date, though mask sales are recovering.
- Forward-Looking Statements: The filing includes standard disclaimers that future results may differ materially from expectations due to risks and uncertainties.
Investor Verification Checklist
- Distributor Concentration: Verify the stability and contract terms with the largest distributor, which accounts for a significant percentage of Apparel sales.
- Margin Sustainability: Confirm if the improved gross margins (43.0%) are sustainable given the increase in SG&A expenses and raw material costs.
- Debt Covenants: Review the terms of the $3,500,000 line of credit and the $198,000 term note expiring in April 2003 for any restrictive covenants.
- Capital Expenditure ROI: Assess the projected return on the planned $800,000 investment in new manufacturing equipment.
- Share Repurchase Program: Monitor the remaining capacity of the $500,000 share buy-back authorization (currently $354,000 utilized as of Oct 18, 2000).